Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ege Dedeoğlu"'
Autor:
Süleyman Yalçın, Yasemin Coşgun, Ege Dedeoğlu, Katharina Kopp, Fatma Bayrakdar, Gültekin Ünal, Biran Musul, Ekrem Sağtaş, Gülay Korukluoğlu, Philomena Raftery, Sedat Kaygusuz
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
BackgroundTürkiye confirmed its first case of SARS-CoV-2 on March 11, 2020, coinciding with the declaration of the global COVID-19 pandemic. Subsequently, Türkiye swiftly increased testing capacity and implemented genomic sequencing in 2020. This p
Externí odkaz:
https://doaj.org/article/c45755b4ee54475c8513bbca9a5c36c9
Autor:
Irena Barbara Padzińska-Pruszyńska, Muhammad Waqas Akbar, Murat Isbilen, Emilia Górka, Baris Kucukkaraduman, Seçil Demirkol Canlı, Ege Dedeoğlu, Shila Azizolli, Isli Cela, Abbas Guven Akcay, Hasim Hakanoglu, Lubomir Bodnar, Szczepan Cierniak, Zygmunt Kozielec, Jacek Jerzy Pruszyński, Martyna Bittel, Ali Osmay Gure, Magdalena Król, Bartłomiej Taciak
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 11, p 6054 (2024)
This research paper presents a novel approach to identifying biomarkers that can be used to prognosticate patients with triple-negative breast cancer (TNBC) eligible for neoadjuvant therapy. The study utilized survival and RNA sequencing data from a
Externí odkaz:
https://doaj.org/article/8fc95949f8e74d3281e6c5178f6a60af
Autor:
Seçil Demirkol Canlı, Ege Dedeoğlu, Muhammad Waqas Akbar, Barış Küçükkaraduman, Murat İşbilen, Özge Şükrüoğlu Erdoğan, Seda Kılıç Erciyas, Hülya Yazıcı, Burçak Vural, Ali Osmay Güre
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0231835 (2020)
Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal cancers. Known risk factors for this disease are currently insufficient in predicting mortality. In order to better prognosticate patients with PDAC, we identified 20 genes by utilizing
Externí odkaz:
https://doaj.org/article/7dc249d8a4724757b9e2865e55513c71
Autor:
Secil Demirkol Canli, Ozge Sukruoglu Erdogan, Murat Isbilen, Hulya Yazici, Muhammad Waqas Akbar, Baris Kucukkaraduman, Burçak Vural, Ali O. Gure, Seda Kilic Erciyas, Ege Dedeoğlu
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 4, p e0231835 (2020)
PLoS ONE, Vol 15, Iss 4, p e0231835 (2020)
Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal cancers. Known risk factors for this disease are currently insufficient in predicting mortality. The only FDA approved prognostic biomarker for PDAC patients is CA19-9. This, along with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81c8af01a2a72cc8c842a566792c22d4
https://hdl.handle.net/11693/75674
https://hdl.handle.net/11693/75674